Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-14-016512
Filing Date
2014-03-18
Accepted
2014-03-18 20:44:13
Documents
1
Period of Report
2014-03-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v372122_4a.html 4/A  
1 OWNERSHIP DOCUMENT v372122_4a.xml 4/A 7102
  Complete submission text file 0001144204-14-016512.txt   8525
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
RAYNOR DANIEL (Reporting) CIK: 0001068854 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31812 | Film No.: 14702502